These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 37073715)
1. Identification of an immune-related genes signature to predict risk of recurrence for patients with laryngeal squamous cell carcinoma. Hong X; Li Y; Lv Q; An J; Liu Y; Wang X; Li R; Hu Y; Liu B Int J Immunopathol Pharmacol; 2023; 37():3946320231172075. PubMed ID: 37073715 [TBL] [Abstract][Full Text] [Related]
2. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma. Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677 [TBL] [Abstract][Full Text] [Related]
3. An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma. Qian L; Ni T; Fei B; Sun H; Ni H BMC Cancer; 2022 May; 22(1):545. PubMed ID: 35568824 [TBL] [Abstract][Full Text] [Related]
4. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma. Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of immune-related genes in laryngeal squamous cell carcinoma. Liu W; Zhang C; Gong X; Liao W; Xu J; Zhang X Transl Cancer Res; 2020 Oct; 9(10):6287-6302. PubMed ID: 35117238 [TBL] [Abstract][Full Text] [Related]
6. Identification of a Prognostic Model Based on Immune-Related Genes of Lung Squamous Cell Carcinoma. Li R; Liu X; Zhou XJ; Chen X; Li JP; Yin YH; Qu YQ Front Oncol; 2020; 10():1588. PubMed ID: 33014809 [TBL] [Abstract][Full Text] [Related]
7. Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes. Mo BY; Li GS; Huang SN; Wei ZX; Su YS; Dai WB; Ruan L Med Sci Monit; 2020 Dec; 26():e928185. PubMed ID: 33361747 [TBL] [Abstract][Full Text] [Related]
8. Smoking patients with laryngeal cancer screened with a novel immunogenomics-based prognostic signature. Shen Y; Zhou H; Dong S; Dong W; Zhang L Front Genet; 2022; 13():961764. PubMed ID: 35910213 [TBL] [Abstract][Full Text] [Related]
9. Development of an Immune-Related Risk Signature for Predicting Prognosis in Lung Squamous Cell Carcinoma. Fu D; Zhang B; Yang L; Huang S; Xin W Front Genet; 2020; 11():978. PubMed ID: 33005178 [TBL] [Abstract][Full Text] [Related]
10. Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma. She Y; Kong X; Ge Y; Yin P; Liu Z; Chen J; Gao F; Fang S Cancer Cell Int; 2020; 20():22. PubMed ID: 31988638 [TBL] [Abstract][Full Text] [Related]
11. A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer. Zhao R; Xie C; Gong Y; Wei S; Yuan M; Gan J; Chen W J Oncol; 2022; 2022():5468858. PubMed ID: 36467500 [TBL] [Abstract][Full Text] [Related]
12. Identification and validation of methylation-driven genes prognostic signature for recurrence of laryngeal squamous cell carcinoma by integrated bioinformatics analysis. Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G Cancer Cell Int; 2020; 20():472. PubMed ID: 33005105 [TBL] [Abstract][Full Text] [Related]
13. Cuproptosis-related LINC02454 as a biomarker for laryngeal squamous cell carcinoma based on a novel risk model and in vitro and in vivo analyses. Zhu Q; Zhang R; Lu F; Zhang X; Zhang D; Zhang Y; Chen E; Han F; Zha D J Cancer Res Clin Oncol; 2023 Nov; 149(16):15185-15206. PubMed ID: 37639011 [TBL] [Abstract][Full Text] [Related]
14. Construction of a novel MPT-driven necrosis-related lncRNAs signature for prognosis prediction in laryngeal squamous cell carcinoma. Liu J; Zhang M; Sun Q; Qin X; Gao T; Xu Y; Han S; Zhang Y; Guo Z Environ Sci Pollut Res Int; 2023 Jul; 30(31):77210-77225. PubMed ID: 37249774 [TBL] [Abstract][Full Text] [Related]
15. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma. Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188 [No Abstract] [Full Text] [Related]
16. A novel signature derived from metabolism-related genes GPT and SMS to predict prognosis of laryngeal squamous cell carcinoma. Shen Y; Huang Q; Zhang Y; Hsueh CY; Zhou L Cancer Cell Int; 2022 Jul; 22(1):226. PubMed ID: 35804447 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of a microRNA-pair signature in laryngeal squamous cell carcinoma patients. Zhou S; Meng Q; Wang Z Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4451-4460. PubMed ID: 35478043 [TBL] [Abstract][Full Text] [Related]
18. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma. Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167 [TBL] [Abstract][Full Text] [Related]
19. Development and verification of a hypoxia- and immune-associated prognosis signature for esophageal squamous cell carcinoma. Lian L; Teng SB; Xia YY; Shen XM; Zheng Y; Han SG; Wang WJ; Xu XF; Zhou C J Gastrointest Oncol; 2022 Apr; 13(2):462-477. PubMed ID: 35557566 [TBL] [Abstract][Full Text] [Related]
20. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma. Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]